• Basu, J., Mikhail, M. S., Payraudeau, P. H., Palan, P. R. and Romney, S. L., Smoking and the antioxidant ascorbic acid: plasma, leukocyte, and cervicovaginal cell concentrations in normal healthy women. Amer. J. Obstet. Gynecol., 163, 19481952 (1990).
  • Begrens, W. A. and Madere, R., A highly sensitive high performance liquid chromatography method for the estimation of ascorbic and dehydroascorbic acid in the tissues, biological fluid, and foods. Anal. Biochem., 165, 102107 (1987).
  • Bendich, A., Antioxidant micronutrients and immune responses. Ann. N. Y. Acad. Sci., 587, 168180 (1990).
  • Bosch, F. X., Manos, M. M., Munoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R. and Shah, K. V., Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J. nat. Cancer Inst., 87, 796802 (1995).
  • Burk, R. D., Ho, G. Y. F., Beardsley, L., Lempa, M., Peters, M. and Bierman, R., Sexual behavior and partner characteristics are the predominant risk factors for genital HPV infection in young women. J. infect. Dis., 174, 679689 (1996).
  • Hecht, J. L., Kadish, A. S., Jiang, G. and Burk, R. D., Genetic characterization of the human papillomavirus (HPV) 18 E2 gene in clinical specimens suggests the presence of a subtype with decreased oncogenic potential. Int. J. Cancer, 60, 369376 (1995).
  • Henson, D. E., Block, G. and Levine, M., Ascorbic acid: biologic functions and relation to cancer. J. nat. Cancer Inst., 83, 547550 (1991).
  • Ho, G. Y. F., Bierman, R., Beardsley, L., Chang, C. J. and Burk, R. D., Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med., 338, 423428 (1998a).
  • Ho, G. Y. F., Burk, R. D., Klein, S., Kadish, A. S., Chang, C. J., Palan, P., Basu, J., Tachezy, R., Lewis, R. and Romney, S., Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J. nat. Cancer Inst., 87, 13651371 (1995).
  • Ho, G. Y. F., Kadish, A. S., Burk, R. D., Basu, J., Palan, P. R., Mikhail, M. and Romney, S. L., HPV 16 and cigarette smoking as risk factors for high grade cervical intraepithelial neoplasia. Int. J. Cancer, (1998b). (In press.) Kadish, A. S., Ho, G. Y. F., Burk, R. D., Wang, Y., Romney, S. L., Ledwidge, R. and Angeletti, R. H., Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia. J. nat. Cancer Inst., 89, 12851293 (1997).
  • Kjaer, S. K., Van den Brule, A. J. C., Bock, J. E., Poll, P. A., Engholm, G., Sherman, M. E., Walboomers, J. M. M. and Meijer, C. J. L. M., Human papillomavirus, the most significant risk determinant of cervical intraepithelial neoplasia. Int. J. Cancer, 65, 601606 (1996).
  • Koutsky, L. A., Holmes, K. K., Critchlow, C. W., Stevens, C. E., Paavonen, J., Beckmann, A. M., DeRouen, T. A., Galloway, D. A., Vernon, D. and Kiviat, N. B., A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N. Engl. J. Med., 327, 12721278 (1992).
  • Liaw, K.-L. and 14 others, Human papillomavirus and cervical neoplasia: a case-control study in Taiwan. Int. J. Cancer, 62, 565571 (1995).
  • Niki, E., Noguchi, N., Tsuchihashi, H. and Gotoh, N., Interaction among vitamin C, vitamin E, and b-carotene. Amer. J. clin. Nutr., 62 (Suppl.), 1322S1326S (1995).
  • Palan, P. R., Mikhail, M. S., Basu, J. and Romney, S. L., Plasma levels of antioxidant b-carotene and a-tocopherol in uterine cervix dysplasias and cancer. Nutr. Cancer, 15, 1320 (1991).
  • Palan, P. R., Romney, S. L., Vermund, S. H., Mikhail, M. G. and Basu, J., Effects of smoking and oral contraception on plasma β-carotene levels in healthy women. Amer. J. Obstet. Gynecol., 161, 881885 (1989).
  • Potischman, N. and Brinton, L. A., Nutrition and cervical neoplasia. Cancer Causes Control, 7, 113126 (1996).
  • Qu, W., Jiang, G., Cruz, Y., Chang, C. J., Ho, G. Y. F., Klein, R. S. and Burk, R. D., PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J. clin. Microbiol. 35, 13041310 (1997).
  • Romney, S. L., Ho, G. Y. F., Palan, P. R., Basu, J., Kadish, A. S., Klein, S., Mikhail, M., Hagan, R. J., Chang, C. J. and Burk, R. D., Effects of b-carotene and other factors on outcome of cervical dysplasia and human papillomavirus infection. Gynecol. Oncol., 65, 483492 (1997).
  • Sies, H. and Stahl, W., Vitamins E and C, β-carotene, and other carotenoids as antioxidants. Amer. J. clin. Nutr., 62 (Suppl.), 1315S1321S (1995).
  • Syrjanen, K., Kataja, V., Yliskoski, M., Chang, F., Syrjanen, S. and Saarikoski, S., Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda system. Obstet. Gynecol., 79, 675682 (1992).